T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECHO
1276
EchoStar
ECHO
$26.6B
| $12M | ﹤0.01% |
403,379
-2,062
| -0.5% | -$68K |
|
1277
NETSCOUT
NTCT
$2.87B
| $12M | ﹤0.01% |
507,001
-37,618
| -7% | -$948K |
|
1278
Editas Medicine
EDIT
$432M
| $11.9M | ﹤0.01% |
524,889
-247,819
| -32% | -$6.74M |
|
1279
Moderna
MRNA
$25.4B
| $11.9M | ﹤0.01% |
+813,442
| New | +$13.4M |
|
1280
Fate Therapeutics
FATE
$317M
| $11.8M | ﹤0.01% |
916,624
+103,429
| +13% | +$1.44M |
|
|
FL
1281
DELISTED
Foot Locker
FL
| $11.8M | ﹤0.01% |
220,893
-730
| -0.3% | -$36.6K |
|
1282
Knight Transportation
KNX
$11.6B
| $11.8M | ﹤0.01% |
468,745
-297,154
| -39% | -$9.2M |
|
|
ARD
1283
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $11.7M | ﹤0.01% |
1,055,731
-5,701
| -0.5% | -$76.6K |
|
|
VER
1284
DELISTED
VEREIT, Inc.
VER
| $11.5M | ﹤0.01% |
320,843
-28,082
| -8% | -$1.04M |
|
1285
Cibus
CBUS
$145M
| $11.3M | ﹤0.01% |
21,893
-11,229
| -34% | -$6.72M |
|
1286
Unum
UNM
$14.5B
| $11.3M | ﹤0.01% |
383,825
| – | – |
|
1287
Innoviva
INVA
$1.5B
| $11.2M | ﹤0.01% |
642,983
+116,107
| +22% | +$1.89M |
|
|
IMGN
1288
DELISTED
Immunogen Inc
IMGN
| $11.2M | ﹤0.01% |
2,337,293
+66,546
| +3% | +$404K |
|
|
FTSV
1289
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $11.1M | ﹤0.01% |
707,070
+494
| +0.1% | +$7.54K |
|
1290
Axalta
AXTA
$7.98B
| $11.1M | ﹤0.01% |
474,048
+60,170
| +15% | +$1.49M |
|
|
ESTE
1291
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $10.9M | ﹤0.01% |
2,422,355
+20,208
| +0.8% | +$153K |
|
|
NGD
1292
DELISTED
New Gold Inc
NGD
| $10.8M | ﹤0.01% |
14,205,251
-1,648,719
| -10% | -$1.33M |
|
|
SFE
1293
DELISTED
Safeguard Scientifics, Inc.
SFE
| $10.8M | ﹤0.01% |
1,247,706
+10,385
| +0.8% | +$90.6K |
|
1294
Copa Holdings
CPA
$6.14B
| $10.7M | ﹤0.01% |
135,583
+45,730
| +51% | +$3.58M |
|
|
FOCS
1295
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $10.6M | ﹤0.01% |
401,163
-855,938
| -68% | -$29.9M |
|
1296
Rigel Pharmaceuticals
RIGL
$782M
| $10.5M | ﹤0.01% |
456,262
+1,550
| +0.3% | +$43.7K |
|
|
ZUO
1297
DELISTED
Zuora, Inc.
ZUO
| $10.2M | ﹤0.01% |
563,264
-145,792
| -21% | -$2.8M |
|
1298
Minerva Neurosciences
NERV
$187M
| $10.1M | ﹤0.01% |
187,081
-28
| -0% | -$2.05K |
|
1299
FS Bancorp
FSBW
$325M
| $10M | ﹤0.01% |
467,430
+3,626
| +0.8% | +$84.6K |
|
1300
Harley-Davidson
HOG
$2.7B
| $9.92M | ﹤0.01% |
290,702
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.